TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• - DeepQure, Inc.
• Equity/Stock(s)/Options - DeepQure, Inc.
• Royalty/Intellectual Property Rights - DeepQure, Inc.
• Industry Salary/Salary Support/Employee (full time or part time) - DeepQure, Inc.